Onconetix (ONCO) Other financing activities (2022 - 2026)

Onconetix (ONCO) has reported Other financing activities for 4 consecutive years, with $384842.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other financing activities fell 23.03% year-over-year to $384842.0 in Q1 2026; TTM through Jun 2026 was $384842.0, a 23.03% decrease from a year earlier, with the FY2025 full-year figure at $500000.0, up 25.0% from the prior year.
• Other financing activities was $384842.0 for Q1 2026 at Onconetix, down from $500000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $9.1 million in Q3 2022 and troughed at -$822937.0 in Q1 2022.
• A 4-year average of $2.8 million and a median of $500000.0 in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities grew 25.0% in 2025 and slipped 23.03% in 2026, its largest moves.
• Over 4 years, Other financing activities stood at $1.9 million in 2022, then sank by 79.29% to $400000.0 in 2024, then gained by 25.0% to $500000.0 in 2025, then slipped by 23.03% to $384842.0 in 2026.
• The last three Other financing activities figures came in at $384842.0 (Q1 2026), $500000.0 (Q1 2025), and $400000.0 (Q1 2024), per Business Quant data.